Eightco Holdings Inc. (ORBS): Nasdaq/NYSE listing notice — Eightco gets second Nasdaq delisting notice for equity shortfall; appeals hearing May 28

Eightco Holdings Inc.

Received second staff determination letter for failing to maintain $2,500,000 minimum stockholders' equity.
Previously failed to regain compliance with minimum bid price rule; cure period ended March 27, 2024.
Appeal hearing scheduled for May 28, 2024 to contest both deficiencies; trading continues pending appeal.
Company intends to resolve deficiencies but warns no guarantee of regaining compliance or avoiding delisting.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Eightco Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5810(c)(3)(A)

Exact text from the filing

March 28, 2024, the Company received a staff determination letter (the “Staff Determination Letter”) from Nasdaq informing the Company that the Company had not regained compliance with the Minimum Bid Price Rule. The Staff Determination Letter noted that unless the Company requested an appeal of the staff’s determination, the Company’s securities would be scheduled for delisting from The Nasdaq Capital Market. On April 9, 2024, the Company received a second staff determination letter (the “Additional Staff Determination Letter”) from Nasdaq indicating that the Company was also not in complianc

View on SEC.gov

50 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Eightco Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-014456

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.